JP2022512946A5 - - Google Patents
Info
- Publication number
- JP2022512946A5 JP2022512946A5 JP2021524375A JP2021524375A JP2022512946A5 JP 2022512946 A5 JP2022512946 A5 JP 2022512946A5 JP 2021524375 A JP2021524375 A JP 2021524375A JP 2021524375 A JP2021524375 A JP 2021524375A JP 2022512946 A5 JP2022512946 A5 JP 2022512946A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- ophthalmic
- eye
- preparation
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025004218A JP2025061211A (ja) | 2018-11-08 | 2025-01-10 | 自己抗体媒介性眼疾患の治療および診断 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862757641P | 2018-11-08 | 2018-11-08 | |
| US62/757,641 | 2018-11-08 | ||
| US201962855253P | 2019-05-31 | 2019-05-31 | |
| US62/855,253 | 2019-05-31 | ||
| PCT/US2019/060566 WO2020097528A1 (en) | 2018-11-08 | 2019-11-08 | Treatment and diagnosis of autoantibody-mediated eye diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025004218A Division JP2025061211A (ja) | 2018-11-08 | 2025-01-10 | 自己抗体媒介性眼疾患の治療および診断 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022512946A JP2022512946A (ja) | 2022-02-07 |
| JP2022512946A5 true JP2022512946A5 (cg-RX-API-DMAC7.html) | 2022-11-15 |
| JP7624220B2 JP7624220B2 (ja) | 2025-01-30 |
Family
ID=69056109
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021524375A Active JP7624220B2 (ja) | 2018-11-08 | 2019-11-08 | 自己抗体媒介性眼疾患の治療および診断 |
| JP2025004218A Pending JP2025061211A (ja) | 2018-11-08 | 2025-01-10 | 自己抗体媒介性眼疾患の治療および診断 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025004218A Pending JP2025061211A (ja) | 2018-11-08 | 2025-01-10 | 自己抗体媒介性眼疾患の治療および診断 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220062337A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3877406A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7624220B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210093274A (cg-RX-API-DMAC7.html) |
| CN (1) | CN113631570B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019377552B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021008548A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3118367A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021005352A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020097528A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT202100002306A1 (it) * | 2021-02-03 | 2022-08-03 | Univ Degli Studi Roma La Sapienza | Procedimento e kit per la diagnosi in vitro della sindrome da anticorpi anti-fosfolipidi |
| US11951123B2 (en) * | 2022-01-12 | 2024-04-09 | Platform Ophthalmic Innovations, LLC | Fortified nutritional lubricating drops for dry eye disease |
| WO2023201283A2 (en) * | 2022-04-13 | 2023-10-19 | The Regents Of The University Of California | Methods of producing plasma or serum and uses thereof |
| WO2024077068A1 (en) * | 2022-10-06 | 2024-04-11 | Oklahoma Medical Research Foundation | Anti-vimentin antibodies are associated with higher severity of sjögren's syndrome |
| WO2024136368A1 (ko) * | 2022-12-21 | 2024-06-27 | 건국대학교 산학협력단 | α-2,6-시알산화 면역글로불린의 안구 건조증 또는 염증성 안과 질환의 예방 또는 치료 용도 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6984492B2 (en) | 2003-09-05 | 2006-01-10 | Talecris Biotherapeutics, Inc. | Methods and compositions for treating herpes infections |
| CA2888519C (en) | 2012-10-17 | 2023-02-21 | Liverpool School Of Tropical Medicine | Immunomodulatory proteins |
| US9107906B1 (en) * | 2014-10-28 | 2015-08-18 | Adma Biologics, Inc. | Compositions and methods for the treatment of immunodeficiency |
-
2019
- 2019-11-08 WO PCT/US2019/060566 patent/WO2020097528A1/en not_active Ceased
- 2019-11-08 BR BR112021008548-3A patent/BR112021008548A2/pt unknown
- 2019-11-08 KR KR1020217017045A patent/KR20210093274A/ko not_active Ceased
- 2019-11-08 MX MX2021005352A patent/MX2021005352A/es unknown
- 2019-11-08 US US17/292,094 patent/US20220062337A1/en active Pending
- 2019-11-08 AU AU2019377552A patent/AU2019377552B2/en active Active
- 2019-11-08 CA CA3118367A patent/CA3118367A1/en active Pending
- 2019-11-08 JP JP2021524375A patent/JP7624220B2/ja active Active
- 2019-11-08 CN CN201980088314.2A patent/CN113631570B/zh active Active
- 2019-11-08 EP EP19828910.0A patent/EP3877406A1/en active Pending
-
2025
- 2025-01-10 JP JP2025004218A patent/JP2025061211A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nussenblatt et al. | Effectiveness of cyclosporin therapy for Beh¸ let's disease | |
| Ishibashi et al. | Oral itraconazole and topical miconazole with debridement for Acanthamoeba keratitis | |
| CN103037857B (zh) | 用于治疗/预防眼部炎性疾病的化合物 | |
| JP7624220B2 (ja) | 自己抗体媒介性眼疾患の治療および診断 | |
| JP2022526917A (ja) | 眼科用製剤およびその使用 | |
| TW202400215A (zh) | 用於血管新生眼睛病症之治療之延長高劑量vegf拮抗劑方案 | |
| JP7309816B2 (ja) | 結節性痒疹患者における皮膚病変およびそう痒の治療 | |
| JP2022516099A (ja) | 眼科用医薬組成物及び癌表面疾患の処置方法 | |
| US20220034903A1 (en) | Therapies That Target Autoimmunity For Treating Glaucoma And Optic Neuropathy | |
| TW202128746A (zh) | 融合蛋白在治療年齡相關性黃斑變性中的應用 | |
| Dolz-Marco et al. | Rituximab in refractory Vogt–Koyanagi–Harada disease | |
| Meira et al. | Sustained control from recurring non-infectious uveitic macular edema with 0.19 mg fluocinolone acetonide intravitreal implant–a case report | |
| JP2020525416A (ja) | 眼表面障害の治療及び診断 | |
| RU2021116163A (ru) | Лечение и диагностика опосредованных аутоантителами глазных заболеваний | |
| CN118510520A (zh) | 用于治疗眼部疾病的霉酚酸和/或倍他米松的药物组合物 | |
| Secchi et al. | Open noncontrolled multicenter long-term trial with ciclosporin in endogenous non-infectious uveitis | |
| Wizemann et al. | Therapeutic effects of short-term plasma exchange in endogenous uveitis | |
| RU2668713C1 (ru) | Способ лечения центральных язв роговицы бактериальной и герпетической этиологии | |
| RU2845362C2 (ru) | Лечение и диагностика опосредованных аутоантителами глазных заболеваний | |
| Davis et al. | Eales' disease: the great masquerader | |
| RU2837046C1 (ru) | Применение ингибиторов btk при лечении заболеваний | |
| RU2822134C2 (ru) | Лечение поражений кожи и зуда у пациентов с узловатой почесухой | |
| RU2107480C1 (ru) | Способ лечения эндогенных и послеоперационных увеитов | |
| WO2025106642A1 (en) | Methods for the treatment of thyroid eye disease | |
| RU2772202C2 (ru) | Лечение гнойного гидраденита |